Arizona HB2965 prohibits interference in the distribution of 340B drugs to covered entities.
Arizona HB2965 amends state law to prohibit manufacturers, repackagers, or their affiliates from requiring 340B covered entities to submit claims or utilization data as a condition for acquiring or delivering 340B drugs, unless mandated by the U.S. Department of Health and Human Services. The Arizona State Board of Pharmacy is authorized to investigate violations and may impose discipline, suspension, or revocation of licenses. The Attorney General can enforce the law, and each package subject to a prohibited act constitutes a separate violation.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.